CRKN · As filed with the SEC

Crown Electrokinetics cash flow statement, by fiscal year

The statement as Crown Electrokinetics presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.

Consolidated Statements of Cash Flows · USD thousands

USD thousands	FY2024 Year ended Dec 31, 2024	FY2023 Year ended Dec 31, 2023	FY2022 Year ended Dec 31, 2022	FY2021 Year ended Mar 31, 2021
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	—	—	—	(40,755.13)
Net loss	(25,946)	(28,984)	(14,315)	—
Stock-based compensation	—	—	2,405	—
Issuance of common stock to consultants	—	—	—	305.44
Depreciation and amortization	—	—	503	102.84
Stock-based compensation and employee inducement award	5,250	714	—	14,126.00
Depreciation and amortization	1,115	733	—	—
Loss on extinguishment of warrant liability	0	504	—	—
Change in fair value of warrant liability	0	(10,458)	—	—
Change in fair value of derivative liability	0	(401)	—	—
Gain on issuance of convertible note	0	(64)	—	—
Loss on extinguishment of debt	0	2,345	—	14,257.50
Loss on exchange of notes payable for common stock and warrants	—	—	—	1,527.18
Amortization of debt discount	—	—	—	2,713.52
Non-cash expenses for placement agent	—	—	—	54.96
Change in fair value of warrant liability	—	—	—	2,360.54
Change in fair value of warrant liability	—	—	(1,023)	12.71
Change in fair value of notes	0	7,040	149	—
Amortization of deferred issuance costs	1,306	9,341	73	—
Amortization of right-of-use assets	780	626	494	—
Other expenses	—	628	—	—
Impairment of goodwill	0	649	—	—
Intangible asset impairment	0	200	—	—
Loss on lease termination	0	214	—	—
Loss on disposal of equipment	0	144	52	—
Realized loss from ELOC derivative	800	—	—	—
Other non-cash expenses	23	—	—	—
Changes in operating assets and liabilities:
Prepaid and other assets	192	61	182	(353.32)
Accounts and retention receivables	(5,275)	(83)	—	—
Accounts payable	—	1,253	413	(802.40)
Accrued expenses	—	—	323	420.10
Lease liability	—	—	(396)	—
Contract assets	(2,058)	—	—	—
Accounts payable	1,104	—	—	—
Accounts payable - related party	2,762	—	—	—
Accrued expenses and other current liabilities	2,451	440	—	(554.30)
Lease liabilities	(685)	(1,062)	—	—
Net cash used in operating activities	(18,181)	(16,160)	(11,140)	(6,584.38)
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of equipment	—	—	(751)	(158.86)
Purchase of patents	—	—	—	(1,475)
Cash paid for acquisition of Amerigen 7	—	(645)	—	—
Cash paid for acquisition of Amerigen 7	0	—	—	—
Purchases of property and equipment	(6,145)	(2,173)	—	—
Purchase of patents	—	—	(61)	—
Advances on note receivable	(243)	—	—	—
Repayments of note receivable	181	—	—	—
Net cash used in investing activities	(6,207)	(2,818)	(812)	(1,633.86)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from the exercise of warrants	0	2,062	—	—
Proceeds from the issuance of common stock / at-the-market offering, net of issuance costs	21,274	—	855	20,925.11
Proceeds from related party non-interest bearing advance	—	—	—	25
Proceed from the exercise of common stock warrants	—	—	—	179.98
Proceeds from the issuance of common stock / At-the-market offering	—	8,398	1,295	—
Proceeds from the issuance of notes in connection with line-of-credit	0	2,350	—	—
Offering costs for the issuance of common stock / At-the-market offering	—	(170)	(46)	—
Proceeds from issuance of senior secured convertible notes and common stock warrants	—	—	3,500	—
Proceeds from issuance of Series D preferred stock and warrants, net of fees	—	—	1,039	—
Proceeds from issuance of Series F-1 preferred stock	0	2,328	—	—
Proceeds from issuance of Series F-2 preferred stock	0	748	—	—
Proceeds from issuance of January promissory notes, net of fees paid	—	1,357	—	—
Repayment of senior secured promissory note	—	—	—	(200)
Proceeds from PPP loan	—	—	—	438.5
Repayment of related party non-interest bearing advance	—	—	—	(74.74)
Proceeds from issuance of Senior Secured Notes, net of fees paid	0	—	—	—
Payments of notes payable	(99)	(2,348)	—	(53)
Proceeds from issuance of senior secured convertible notes and common stock warrants	—	—	—	2,676
Common stock repurchased and subsequently canceled	—	—	—	(450)
Proceeds from the issuance of common stock in connection with equity line of credit, net of offering costs	—	4,489	—	—
Proceeds from lines-of-credit	1,118	—	—	—
Repayments of lines-of-credit	(1,118)	—	—	—
Proceeds from the issuance of common stock in connection with equity line-of-credit, net of issuance costs	15,853	—	—	—
Net cash provided by financing activities	37,028	19,214	6,643	23,466.86
Net decrease in cash	—	—	(5,309)	15,248.62
Net increase in cash	12,640	238	—	—
Cash — beginning of the year	1,059	821	6,130	48.31
Cash — end of year	—	—	—	15,296.92
Cash — end of the year	13,699	1,059	821	—
SUPPLEMENTAL CASH FLOW INFORMATION
Cash paid for interest	214	14	7	62.65
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
Beneficial conversion feature in connection with notes payable	—	—	—	618.66
Cumulative dividends on Series A preferred stock	251	—	—	—
Cumulative dividends on Series B preferred stock	1,530	—	—	—
Cumulative dividends on Series C preferred stock	501	—	—	—
Series F Preferred Stock	4,438	—	—	—
Series F-1 Preferred Stock Converted To Common Stock	653	—	—	—
Series F-2 Preferred Stock Converted To Common Stock	1,163	—	—	—
Preferred Stock Series A, B and C	2,147	—	—	—
Series F-1, F-2 and F-3 Preferred Stock	3,874	—	—	—
Issuance of Series E preferred stock in connection with line of credit	0	4,350	—	—
Issuance of common stock in connection with equity line of credit	0	114	—	—
Issuance of Series F preferred stock in connection with exchange of Series D preferred stock	—	450	—	—
Issuance of Series F preferred stock in connection with exchange of Series D preferred stock	0	—	—	—
Issuance of common stock in connection with conversion of notes	0	2,165	—	23,715.83
Repurchased beneficial conversion feature in connection with conversion of notes payable	—	—	—	(6,647.00)
Issuance of common stock in connection with notes payable	—	—	—	1,133.65
Issuance of common stock in satisfaction of accounts payable	—	—	—	121.84
Canceled restricted stock awards	—	—	—	0.21
Reclassification of warrant liabilities	—	—	—	5,626.89
Issuance of common stock warrants in connection with note exchange agreements	—	—	—	4,918.17
Issuance of common stock warrants in connection with notes payable	—	—	—	263.33
Exercise of stock options	—	—	—	0.00
Issuance of common stock in connection with Senior Secured Notes settlement	0	1,160	—	—
Issuance of common stock warrants in connection with SLOC	—	—	223	—
Conversion of Senior Secured Notes into Series F preferred stock in connection with Exchange Agreements	0	82	—	—
Issuance of common stock warrants in connection with consideration payable	—	—	86	—
Acquisitions of property and equipment included in liabilities	—	452	94	—
Commitment to issue shares of common stock in connection with Demand Notes	0	286	—	—
Acquisitions of property and equipment included in liabilities	71	—	—	—
Property and equipment acquired through notes payable	634	—	—	—
Right-of-use assets in exchange of operating lease liabilities	560	1,168	—	—
Reduction of right-of-use assets and lease liability due to termination	0	853	—	—

As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.